According to The Kobeissi Letter, UnitedHealth Group's stock ($UNH) has dropped by 12% following the announcement of a civil fraud probe by the US Department of Justice into the company's Medicare billing practices. This significant decline in stock value highlights investors' concerns over potential legal and financial repercussions that could impact future profitability and market confidence.